FGEN
FibroGen Inc
Price:  
1.89 
USD
Volume:  
1,604,764.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

FGEN EV/EBITDA

-2519.0%
Upside

As of 2024-02-23, the EV/EBITDA ratio of FibroGen Inc (FGEN) is -0.61. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. FGEN's latest enterprise value is 165.37 mil USD. FGEN's TTM EBITDA according to its financial statements is -270.45 mil USD. Dividing these 2 quantities gives us the above FGEN EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 12.0x - 22.5x 17.0x
Forward P/E multiples 17.4x - 20.1x 18.6x
Fair Price (44.74) - (51.77) (45.72)
Upside -2467.1% - -2839.2% -2519.0%
1.89 USD
Stock Price
(45.72) USD
Fair Price

FGEN EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-02-22 -0.67
2024-02-21 -0.61
2024-02-20 -0.64
2024-02-16 -0.78
2024-02-15 -0.76
2024-02-14 -0.80
2024-02-13 -0.77
2024-02-12 -0.97
2024-02-09 -0.97
2024-02-08 -0.85
2024-02-07 -0.77
2024-02-06 -0.68
2024-02-05 -0.72
2024-02-02 -0.66
2024-02-01 -0.84
2024-01-31 -0.68
2024-01-30 -0.61
2024-01-29 -0.61
2024-01-26 -0.33
2024-01-25 -0.39
2024-01-24 -0.34
2024-01-23 -0.32
2024-01-22 -0.31
2024-01-19 -0.27
2024-01-18 -0.28
2024-01-17 -0.27
2024-01-16 -0.27
2024-01-12 -0.27
2024-01-11 -0.29
2024-01-10 -0.30
2024-01-09 -0.32
2024-01-08 -0.28
2024-01-05 -0.27
2024-01-04 -0.26
2024-01-03 -0.28
2024-01-02 -0.30
2023-12-29 -0.32
2023-12-28 -0.32
2023-12-27 -0.29
2023-12-26 -0.28
2023-12-22 -0.27
2023-12-21 -0.25
2023-12-20 -0.20
2023-12-19 -0.22
2023-12-18 -0.23
2023-12-15 -0.24
2023-12-14 -0.24
2023-12-13 -0.26
2023-12-12 -0.22
2023-12-11 -0.22